Children's Cancer Group, China

This study is testing a modified version of a standard chemotherapy regimen (ALCL99) for Chinese children and adolescents newly diagnosed with a high-risk type of lymphoma. The goal is to see if this adapted treatment plan can improve long-term survival and reduce side effects co…

This study is testing whether adding a targeted drug called rituximab and using higher doses of chemotherapy can improve survival for children and adolescents with advanced forms of B-cell lymphoma or leukemia. It compares this new approach to a previous treatment plan used in Ch…

This study is testing a well-established cancer treatment plan, originally developed in the U.S., on Chinese children and teenagers newly diagnosed with Hodgkin lymphoma. The goal is to see if this plan works as effectively in China, where the disease is rarer and drug access can…

This study aims to improve survival rates for Chinese children and adolescents newly diagnosed with lymphoblastic lymphoma, a rare and aggressive cancer. Researchers are testing a modified version of a standard chemotherapy regimen, adjusting drug doses and treatment length based…